CN111961232A - 高效的医用石墨烯导电凝胶及其制备方法 - Google Patents
高效的医用石墨烯导电凝胶及其制备方法 Download PDFInfo
- Publication number
- CN111961232A CN111961232A CN202010942326.1A CN202010942326A CN111961232A CN 111961232 A CN111961232 A CN 111961232A CN 202010942326 A CN202010942326 A CN 202010942326A CN 111961232 A CN111961232 A CN 111961232A
- Authority
- CN
- China
- Prior art keywords
- graphene
- water
- conductive gel
- parts
- graphene conductive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title claims abstract description 63
- 229910021389 graphene Inorganic materials 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000001879 gelation Methods 0.000 title description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000002135 nanosheet Substances 0.000 claims abstract description 24
- 229920003169 water-soluble polymer Polymers 0.000 claims abstract description 19
- 230000005855 radiation Effects 0.000 claims abstract description 14
- 239000008346 aqueous phase Substances 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 239000008367 deionised water Substances 0.000 claims description 12
- 229910021641 deionized water Inorganic materials 0.000 claims description 12
- 239000006185 dispersion Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 12
- 239000002077 nanosphere Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 6
- 229920002125 Sokalan® Polymers 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000004132 cross linking Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 229920002401 polyacrylamide Polymers 0.000 claims description 6
- 239000004584 polyacrylic acid Substances 0.000 claims description 6
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 claims description 6
- -1 polyoxyethylene Polymers 0.000 claims description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 6
- 239000002064 nanoplatelet Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 abstract description 24
- 239000000463 material Substances 0.000 abstract description 3
- 239000000017 hydrogel Substances 0.000 abstract description 2
- 239000003999 initiator Substances 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 239000007772 electrode material Substances 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0492—Patch electrodes
- A61N1/0496—Patch electrodes characterised by using specific chemical compositions, e.g. hydrogel compositions, adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2329/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal, or ketal radical; Hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Derivatives of such polymer
- C08J2329/02—Homopolymers or copolymers of unsaturated alcohols
- C08J2329/04—Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/02—Homopolymers or copolymers of acids; Metal or ammonium salts thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/04—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters
- C08J2333/14—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/24—Homopolymers or copolymers of amides or imides
- C08J2333/26—Homopolymers or copolymers of acrylamide or methacrylamide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2339/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Derivatives of such polymers
- C08J2339/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
- C08J2339/06—Homopolymers or copolymers of N-vinyl-pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2371/00—Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
- C08J2371/02—Polyalkylene oxides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K2201/00—Specific properties of additives
- C08K2201/001—Conductive additives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K2201/00—Specific properties of additives
- C08K2201/011—Nanostructured additives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/02—Elements
- C08K3/04—Carbon
- C08K3/042—Graphene or derivatives, e.g. graphene oxides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
本发明涉及石墨烯导电凝胶领域,尤其是高效的医用石墨烯导电凝胶及其制备方法。该石墨烯导电凝胶包括医用石墨烯导电凝胶中各组分的重量份数为:石墨烯纳米片3‑15份,水溶性聚合物7‑35份,水50‑90份。本发明结合水凝胶优异的保水性能、石墨烯材料的优异导电性能和良好的抗菌性能,采用辐射法合成导电凝胶无须添加引发剂,产物更纯净。
Description
技术领域
本发明涉及石墨烯导电凝胶领域,尤其是高效的医用石墨烯导电凝胶及其制备方法。
背景技术
人体的内脏、脑、肌肉、神经等都有“生物电”,这种生物电流会变成信号传输到身体各个部位。低频治疗就是利用这一性质,从外部加入低频刺激达到舒缓痛楚,消除麻痹的作用。传统的理疗仪电极材料主要是铜片外包绒布,使用时必须用水润湿绒布使其导电。这种材料的性能较差。
发明内容
为了克服现有的理疗仪电极材料性能差的不足,本发明提供了高效的医用石墨烯导电凝胶及其制备方法。
本发明解决其技术问题所采用的技术方案是:一种高效的医用石墨烯导电凝胶,所述医用石墨烯导电凝胶中各组分的重量份数为:石墨烯纳米片3-15份,水溶性聚合物7-35份,水50-90份。
根据本发明的另一个实施例,进一步包括所述水溶性聚合物为聚乙烯醇、聚乙烯基吡咯烷酮、聚丙烯酸、聚丙烯酰胺、聚氧乙烯、聚甲基丙烯酸羟乙酯中的一种或多种的混合物。
根据本发明的另一个实施例,进一步包括所述水为医用超纯去离子水。
一种高效的医用石墨烯导电凝胶的制备方法,该制备方法的步骤为:
A、将石墨烯纳米片分散在水中,搅拌分散后,经超高速纳米球磨机进一步分散得到高度分散的石墨烯水相分散液,所述超高速纳米球磨机输出转速为5000~8000rpm;
B、将去离子水中加入反应釜中,并升温至60-70℃,将石墨烯纳米片水相分散液和水溶性聚合物依次加入反应釜中,在300-500rpm转速下继续搅拌30-60分钟;
C、将步骤B所得的混合液室温冷却注入模具,经辐射产生器辐射交联获得石墨烯导电凝胶。
本发明的有益效果是,本发明结合水凝胶优异的保水性能、石墨烯材料的优异导电性能
和良好的抗菌性能,采用辐射法合成导电凝胶无须添加引发剂,产物更纯净。
具体实施方式
一种高效的医用石墨烯导电凝胶,所述医用石墨烯导电凝胶中各组分的重量份数为:石墨烯纳米片3-15份,水溶性聚合物7-35份,水50-90份。
水溶性聚合物为聚乙烯醇、聚乙烯基吡咯烷酮、聚丙烯酸、聚丙烯酰胺、聚氧乙烯、聚甲基丙烯酸羟乙酯中的一种或多种的混合物。
水为医用超纯去离子水。
一种高效的医用石墨烯导电凝胶的制备方法,该制备方法的步骤为:
A、将石墨烯纳米片分散在水中,搅拌分散后,经超高速纳米球磨机进一步分散得到高度分散的石墨烯水相分散液,所述超高速纳米球磨机输出转速为5000~8000rpm;
B、将去离子水中加入反应釜中,并升温至60-70℃,将石墨烯纳米片水相分散液和水溶性聚合物依次加入反应釜中,在300-500rpm转速下继续搅拌30-60分钟;
C、将步骤B所得的混合液室温冷却注入模具,经辐射产生器辐射交联获得石墨烯导电凝胶。
实施例一:
一种高效的医用石墨烯导电凝胶,所述医用石墨烯导电凝胶中各组分的重量份数为:石墨烯纳米片3份,水溶性聚合物7份,水50份。
水溶性聚合物为聚乙烯醇、聚乙烯基吡咯烷酮、聚丙烯酸、聚丙烯酰胺、聚氧乙烯、聚甲基丙烯酸羟乙酯中的一种或多种的混合物。
水为医用超纯去离子水。
一种高效的医用石墨烯导电凝胶的制备方法,该制备方法的步骤为:
A、将石墨烯纳米片分散在水中,搅拌分散后,经超高速纳米球磨机进一步分散得到高度分散的石墨烯水相分散液,所述超高速纳米球磨机输出转速为5000rpm;
B、将去离子水中加入反应釜中,并升温至60℃,将石墨烯纳米片水相分散液和水溶性聚合物依次加入反应釜中,在300rpm转速下继续搅拌30分钟;
C、将步骤B所得的混合液室温冷却注入模具,经辐射产生器辐射交联获得石墨烯导电凝胶。
实施例二:
一种高效的医用石墨烯导电凝胶,所述医用石墨烯导电凝胶中各组分的重量份数为:石墨烯纳米片15份,水溶性聚合物35份,水90份。
水溶性聚合物为聚乙烯醇、聚乙烯基吡咯烷酮、聚丙烯酸、聚丙烯酰胺、聚氧乙烯、聚甲基丙烯酸羟乙酯中的一种或多种的混合物。
水为医用超纯去离子水。
一种高效的医用石墨烯导电凝胶的制备方法,该制备方法的步骤为:
A、将石墨烯纳米片分散在水中,搅拌分散后,经超高速纳米球磨机进一步分散得到高度分散的石墨烯水相分散液,所述超高速纳米球磨机输出转速为8000rpm;
B、将去离子水中加入反应釜中,并升温至70℃,将石墨烯纳米片水相分散液和水溶性聚合物依次加入反应釜中,在500rpm转速下继续搅拌60分钟;
C、将步骤B所得的混合液室温冷却注入模具,经辐射产生器辐射交联获得石墨烯导电凝胶。
实施例三:
一种高效的医用石墨烯导电凝胶,所述医用石墨烯导电凝胶中各组分的重量份数为:石墨烯纳米片9份,水溶性聚合物18份,水74份。
水溶性聚合物为聚乙烯醇、聚乙烯基吡咯烷酮、聚丙烯酸、聚丙烯酰胺、聚氧乙烯、聚甲基丙烯酸羟乙酯中的一种或多种的混合物。
水为医用超纯去离子水。
一种高效的医用石墨烯导电凝胶的制备方法,该制备方法的步骤为:
A、将石墨烯纳米片分散在水中,搅拌分散后,经超高速纳米球磨机进一步分散得到高度分散的石墨烯水相分散液,所述超高速纳米球磨机输出转速为6000rpm;
B、将去离子水中加入反应釜中,并升温至60-70℃,将石墨烯纳米片水相分散液和水溶性聚合物依次加入反应釜中,在400rpm转速下继续搅拌55分钟;
C、将步骤B所得的混合液室温冷却注入模具,经辐射产生器辐射交联获得石墨烯导电凝胶。
Claims (5)
1.一种高效的医用石墨烯导电凝胶,其特征是,所述医用石墨烯导电凝胶中各组分的重量份数为:石墨烯纳米片3-15份,水溶性聚合物7-35份,水50-90份。
3.根据权利要求1所述的高效的医用石墨烯导电凝胶,其特征是,所述水溶性聚合物为聚乙烯醇、聚乙烯基吡咯烷酮、聚丙烯酸、聚丙烯酰胺、聚氧乙烯、聚甲基丙烯酸羟乙酯中的一种或多种的混合物。
4.根据权利要求1所述的高效的医用石墨烯导电凝胶,其特征是,所述水为医用超纯去离子水。
5.根据权利要求1至4中任意一项所述高效的医用石墨烯导电凝胶的制备方法,其特征是,该制备方法的步骤为:
A、将石墨烯纳米片分散在水中,搅拌分散后,经超高速纳米球磨机进一步分散得到高度分散的石墨烯水相分散液,所述超高速纳米球磨机输出转速为5000~8000rpm;
B、将去离子水中加入反应釜中,并升温至60-70℃,将石墨烯纳米片水相分散液和水溶性聚合物依次加入反应釜中,在300-500rpm转速下继续搅拌30-60分钟;
C、将步骤B所得的混合液室温冷却注入模具,经辐射产生器辐射交联获得石墨烯导电凝胶。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010942326.1A CN111961232A (zh) | 2020-09-09 | 2020-09-09 | 高效的医用石墨烯导电凝胶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010942326.1A CN111961232A (zh) | 2020-09-09 | 2020-09-09 | 高效的医用石墨烯导电凝胶及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111961232A true CN111961232A (zh) | 2020-11-20 |
Family
ID=73392771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010942326.1A Pending CN111961232A (zh) | 2020-09-09 | 2020-09-09 | 高效的医用石墨烯导电凝胶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111961232A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150033144A (ko) * | 2013-09-23 | 2015-04-01 | 동아대학교 산학협력단 | 산화그래핀의 광열전환 효과를 이용한 광감응성 수화겔 및 이의 제조방법 |
KR20150121740A (ko) * | 2014-04-21 | 2015-10-30 | 한국원자력연구원 | 방사선을 이용한 그래핀 함유 수화겔의 제조방법 및 이의 활용방법 |
CN107312318A (zh) * | 2017-07-28 | 2017-11-03 | 合肥泓定科技有限公司 | 一种石墨烯导电复合材料及其制备方法 |
CN109206818A (zh) * | 2018-09-08 | 2019-01-15 | 佛山市禅城区诺高环保科技有限公司 | 一种高强度均匀分散型水凝胶的制备方法 |
CN110655663A (zh) * | 2019-10-29 | 2020-01-07 | 索思(苏州)医疗科技有限公司 | 一种医用导电凝胶及其制备方法 |
-
2020
- 2020-09-09 CN CN202010942326.1A patent/CN111961232A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150033144A (ko) * | 2013-09-23 | 2015-04-01 | 동아대학교 산학협력단 | 산화그래핀의 광열전환 효과를 이용한 광감응성 수화겔 및 이의 제조방법 |
KR20150121740A (ko) * | 2014-04-21 | 2015-10-30 | 한국원자력연구원 | 방사선을 이용한 그래핀 함유 수화겔의 제조방법 및 이의 활용방법 |
CN107312318A (zh) * | 2017-07-28 | 2017-11-03 | 合肥泓定科技有限公司 | 一种石墨烯导电复合材料及其制备方法 |
CN109206818A (zh) * | 2018-09-08 | 2019-01-15 | 佛山市禅城区诺高环保科技有限公司 | 一种高强度均匀分散型水凝胶的制备方法 |
CN110655663A (zh) * | 2019-10-29 | 2020-01-07 | 索思(苏州)医疗科技有限公司 | 一种医用导电凝胶及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Modified Ti3C2TX (MXene) nanosheet-catalyzed self-assembled, anti-aggregated, ultra-stretchable, conductive hydrogels for wearable bioelectronics | |
CN103073665B (zh) | 高强度、温度敏感的聚合物-氧化石墨烯复合水凝胶和导电石墨烯复合水凝胶及其制备方法 | |
CN110117369B (zh) | 一种抗菌粘附的导电水凝胶及其制备方法和应用 | |
CN107828067B (zh) | 一种高强度自修复导电磁性pva水凝胶及其制备方法 | |
CN104072820B (zh) | 一种石墨烯基介电弹性体复合材料及其制备方法 | |
CN109771820A (zh) | 一种导电水凝胶电刺激贴片及其制备方法与应用 | |
WO2018218970A1 (zh) | 医用导电水凝胶及其制备方法与应用 | |
CN110358137B (zh) | 一种多孔网络结构石墨烯/聚苯胺复合干凝胶制备方法 | |
CN111825857B (zh) | 一种水凝胶及其制备方法和应用 | |
CN111423600A (zh) | 一种可注射的定向导电水凝胶的制备方法 | |
CN107452457B (zh) | 一种磁性纳米颗粒、制备方法及其应用 | |
Gkanas | In vitro magnetic hyperthermia response of iron oxide MNP’s incorporated in DA3, MCF-7 and HeLa cancer cell lines | |
Zeng et al. | Tailoring food biopolymers into biogels for regenerative wound healing and versatile skin bioelectronics | |
CN111961232A (zh) | 高效的医用石墨烯导电凝胶及其制备方法 | |
CN103006381B (zh) | 一种离子感应贴的制备方法 | |
Liu et al. | Stretchable, self-adhesive, conductive, anti-freezing sodium polyacrylate-based composite hydrogels for wearable flexible strain sensors | |
CN113943428A (zh) | 一种心电检测用导电凝胶及其制备方法 | |
KR101697870B1 (ko) | 토르마린을 이용한 미세전류 전달 장치 및 이를 포함하는 이온영동장치 | |
CN113292674A (zh) | 一种新型粘附和高导电性水凝胶制备方法及应用 | |
CN103126977A (zh) | 一种智能纳米银水凝胶 | |
CN112142908A (zh) | 医用石墨烯导电凝胶及其制备方法 | |
CN112768259B (zh) | 一种MXene衍生物/金属纳米复合材料的制备方法及其应用 | |
CN114163665B (zh) | 一种快速成胶的水凝胶及其制备方法与应用 | |
Jia et al. | Preparation of Three-Dimensional Graphene Oxide Electric-Field/Temperature-Sensitive Hydrogels and Transdermal-Controlled Release Drug Delivery Study | |
CN106974760A (zh) | 一种自发热垫毯 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201120 |
|
RJ01 | Rejection of invention patent application after publication |